Mild cognitive impairment: Believe it or not?

Ricardo F. Allegri, Frank B. Glaser, Fernando E. Taragano, Herman Buschke

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Mild cognitive impairment (MCI) was previously defined as a transitional state that can precede dementia, but the condition and the rates of conversion remain controversial. MCI is now the focus of natural history studies, along with Alzheimer's disease (AD) prevention. The objective of our review will be to consider the question of whether MCI is a well enough established entity that it can be a diagnosis in medical practice and a valid target of Alzheimer's prevention therapy. MCI was originally defined by Petersen et al. (1999) as progressive memory loss, prodrome of Alzheimer's disease. More recently MCI has been expanded to other cognitive domains with other potential causes like normal aging, fronto-temporal dementia, and vascular dementia. Despite many consensus conferences, experts cannot agree on critical aspects of the MCI, particularly with respect to its clinical utility. Based on neuropsychological studies, a hippocampal memory profile has been proposed for MCI as prodromal AD. Further research is needed to advance these criteria. We have no doubt, however, that in the future, the diagnosis of AD as disease (not only a dementia syndrome) will be made in the early pre-dementia stage and will be drawn from a combination of neuropsychological, neuro-imaging and CSF biomarkers.

Original languageEnglish (US)
Pages (from-to)357-363
Number of pages7
JournalInternational Review of Psychiatry
Volume20
Issue number4
DOIs
StatePublished - Aug 2008

Fingerprint

Dementia
Alzheimer Disease
Vascular Dementia
Memory Disorders
Cognitive Dysfunction
Natural History
Consensus
Biomarkers
Research
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Mild cognitive impairment : Believe it or not? / Allegri, Ricardo F.; Glaser, Frank B.; Taragano, Fernando E.; Buschke, Herman.

In: International Review of Psychiatry, Vol. 20, No. 4, 08.2008, p. 357-363.

Research output: Contribution to journalArticle

Allegri, Ricardo F. ; Glaser, Frank B. ; Taragano, Fernando E. ; Buschke, Herman. / Mild cognitive impairment : Believe it or not?. In: International Review of Psychiatry. 2008 ; Vol. 20, No. 4. pp. 357-363.
@article{08de2515d7b34b9cb2610fa8f28759ee,
title = "Mild cognitive impairment: Believe it or not?",
abstract = "Mild cognitive impairment (MCI) was previously defined as a transitional state that can precede dementia, but the condition and the rates of conversion remain controversial. MCI is now the focus of natural history studies, along with Alzheimer's disease (AD) prevention. The objective of our review will be to consider the question of whether MCI is a well enough established entity that it can be a diagnosis in medical practice and a valid target of Alzheimer's prevention therapy. MCI was originally defined by Petersen et al. (1999) as progressive memory loss, prodrome of Alzheimer's disease. More recently MCI has been expanded to other cognitive domains with other potential causes like normal aging, fronto-temporal dementia, and vascular dementia. Despite many consensus conferences, experts cannot agree on critical aspects of the MCI, particularly with respect to its clinical utility. Based on neuropsychological studies, a hippocampal memory profile has been proposed for MCI as prodromal AD. Further research is needed to advance these criteria. We have no doubt, however, that in the future, the diagnosis of AD as disease (not only a dementia syndrome) will be made in the early pre-dementia stage and will be drawn from a combination of neuropsychological, neuro-imaging and CSF biomarkers.",
author = "Allegri, {Ricardo F.} and Glaser, {Frank B.} and Taragano, {Fernando E.} and Herman Buschke",
year = "2008",
month = "8",
doi = "10.1080/09540260802095099",
language = "English (US)",
volume = "20",
pages = "357--363",
journal = "International Review of Psychiatry",
issn = "0954-0261",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Mild cognitive impairment

T2 - Believe it or not?

AU - Allegri, Ricardo F.

AU - Glaser, Frank B.

AU - Taragano, Fernando E.

AU - Buschke, Herman

PY - 2008/8

Y1 - 2008/8

N2 - Mild cognitive impairment (MCI) was previously defined as a transitional state that can precede dementia, but the condition and the rates of conversion remain controversial. MCI is now the focus of natural history studies, along with Alzheimer's disease (AD) prevention. The objective of our review will be to consider the question of whether MCI is a well enough established entity that it can be a diagnosis in medical practice and a valid target of Alzheimer's prevention therapy. MCI was originally defined by Petersen et al. (1999) as progressive memory loss, prodrome of Alzheimer's disease. More recently MCI has been expanded to other cognitive domains with other potential causes like normal aging, fronto-temporal dementia, and vascular dementia. Despite many consensus conferences, experts cannot agree on critical aspects of the MCI, particularly with respect to its clinical utility. Based on neuropsychological studies, a hippocampal memory profile has been proposed for MCI as prodromal AD. Further research is needed to advance these criteria. We have no doubt, however, that in the future, the diagnosis of AD as disease (not only a dementia syndrome) will be made in the early pre-dementia stage and will be drawn from a combination of neuropsychological, neuro-imaging and CSF biomarkers.

AB - Mild cognitive impairment (MCI) was previously defined as a transitional state that can precede dementia, but the condition and the rates of conversion remain controversial. MCI is now the focus of natural history studies, along with Alzheimer's disease (AD) prevention. The objective of our review will be to consider the question of whether MCI is a well enough established entity that it can be a diagnosis in medical practice and a valid target of Alzheimer's prevention therapy. MCI was originally defined by Petersen et al. (1999) as progressive memory loss, prodrome of Alzheimer's disease. More recently MCI has been expanded to other cognitive domains with other potential causes like normal aging, fronto-temporal dementia, and vascular dementia. Despite many consensus conferences, experts cannot agree on critical aspects of the MCI, particularly with respect to its clinical utility. Based on neuropsychological studies, a hippocampal memory profile has been proposed for MCI as prodromal AD. Further research is needed to advance these criteria. We have no doubt, however, that in the future, the diagnosis of AD as disease (not only a dementia syndrome) will be made in the early pre-dementia stage and will be drawn from a combination of neuropsychological, neuro-imaging and CSF biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=54249163350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249163350&partnerID=8YFLogxK

U2 - 10.1080/09540260802095099

DO - 10.1080/09540260802095099

M3 - Article

C2 - 18925484

AN - SCOPUS:54249163350

VL - 20

SP - 357

EP - 363

JO - International Review of Psychiatry

JF - International Review of Psychiatry

SN - 0954-0261

IS - 4

ER -